title: EEG in ischaemic stroke: quantitative EEG can uniquely inform (sub-)acute prognoses and clinical management.
abstract: Investigations of (sub-)acute ischaemic stroke (IS) employing quantitative electroencephalographic (QEEG) methods, in concert with other assessments, are reviewed. Numerous outcomes from hundreds of patients collectively indicate that (sub-)acute QEEG indices from standard systems can uniquely inform clinical management, particularly prognostication of outcomes from IS. Two classes of QEEG indices have proven particularly informative. The first quantifies the power of abnormal, slow activity relative to that of faster activity and the second, interhemispheric voltage asymmetry (broadband). Both have been identified as statistically significant predictors of outcomes assessed (via routine clinical scales) in the weeks and months following IS. Furthermore both have demonstrated higher predictive value than concomitant neurological assessments and scales, and to improve upon outcome prediction afforded by neuroimaging alone. These indices also may continuously provide unique, real-time insights into the efficacy of thrombolytic therapy, prior to clinical changes. Two key applications of QEEG which should prove valuable for future clinical management of IS are: (1) continuous, acute monitoring to inform about the efficacy of thrombolysis and decisions about potential additional interventions, and; (2) brief, subacute recording to inform outcome prognostication and clinical decisions about, for example, rehabilitation strategies. Ongoing research and technological developments will continue to facilitate clinical translation of QEEG investigations reviewed herein.
authors.affiliation: UQ Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Australia. finnigan.simon@gmail.com
authors.forename: Simon
authors.initials: S
authors.lastname: Finnigan
authors.forename: Michel J A M
authors.initials: MJ
authors.lastname: van Putten
mesh_terms: D002545:Brain Ischemia / Q000503:physiopathology* / Q000628:therapy*; D019090:Case Management; D004569:Electroencephalography; D006801:Humans; D008991:Monitoring, Physiologic; D011379:Prognosis; D020521:Stroke / Q000503:physiopathology* / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods